A JAMA Internal Medicine study highlighted increased gallbladder disease among semaglutide users, and in 2023, the FDA required label changes to reflect serious gastrointestinal risks
10.1172/jci.insight.93382 Summary Keywords glucagon-like peptide-1 receptor agonists, ocular diseases, glaucoma, diabetic retinopathy, mechanism Citation Xie Z, Yang Z, Tian D and Chen Y (2025) Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
But which specific medications are most often responsible for this
Others respond better to the dual-agonist mechanism
The effect builds with titration, and many patients notice meaningful appetite reduction within the first two weeks
The quality and purity of NAD+ supplements vary considerably , as dietary supplements are not subject to the same manufacturing standards as prescription medications